|
Stoller, James K; Tomashefski Jr, Joseph; Crystal, Ronald G et al. (2005) Mortality in individuals with severe deficiency of alpha1-antitrypsin: findings from the National Heart, Lung, and Blood Institute Registry. Chest 127:1196-204
|
|
Tomashefski Jr, Joseph F; Crystal, Ronald G; Wiedemann, Herbert P et al. (2004) The bronchopulmonary pathology of alpha-1 antitrypsin (AAT) deficiency: findings of the Death Review Committee of the national registry for individuals with Severe Deficiency of Alpha-1 Antitrypsin. Hum Pathol 35:1452-61
|
|
Eden, Edward; Hammel, Jeffrey; Rouhani, Farshid N et al. (2003) Asthma features in severe alpha1-antitrypsin deficiency: experience of the National Heart, Lung, and Blood Institute Registry. Chest 123:765-71
|
|
Schluchter, M D; Stoller, J K; Barker, A F et al. (2000) Feasibility of a clinical trial of augmentation therapy for alpha(1)-antitrypsin deficiency. The Alpha 1-Antitrypsin Deficiency Registry Study Group. Am J Respir Crit Care Med 161:796-801
|
|
(1998) Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin. The Alpha-1-Antitrypsin Deficiency Registry Study Group. Am J Respir Crit Care Med 158:49-59
|
|
McElvaney, N G; Stoller, J K; Buist, A S et al. (1997) Baseline characteristics of enrollees in the National Heart, Lung and Blood Institute Registry of alpha 1-antitrypsin deficiency. Alpha 1-Antitrypsin Deficiency Registry Study Group. Chest 111:394-403
|
|
Turino, G M; Barker, A F; Brantly, M L et al. (1996) Clinical features of individuals with PI*SZ phenotype of alpha 1-antitrypsin deficiency. alpha 1-Antitrypsin Deficiency Registry Study Group. Am J Respir Crit Care Med 154:1718-25
|
|
Schluchter, M D (1992) Methods for the analysis of informatively censored longitudinal data. Stat Med 11:1861-70
|
